To this end, we utilized two syngeneic lymphoma models that do not directly respond to CBLB502, since flagellin can directly interact with TLR5-expressing tumors and subsequently promote tumor growth or inhibit tumor growth depending on the tumor model [12], [13]. The gene discussed is TLR5; the disease is neoplasm.